Kim Tae-han
President and CEO
Samsung BioLogics
Tae Han Kim is President and CEO of Samsung BioLogics. He was previously in charge of strategic business development, as EVP of Samsung Electronics until 2011.
During this role and responsibility, he established a Joint Venture with Quintiles, and another JV with Biogen-Idec for biologics business.
He began his career with Samsung in 1979. He led the business and financial restructuring of Samsung General Chemicals for 1998-2003, and played a key role in establishing a JV with Total, a French Petrochemical company. He played a senior leadership for successful integration of the JV with Total, and executed multiple plant expansion projects for 2004-2007.
He received his Ph D in chemical engineering from the University of Texas at Austin in 1988 under the sponsorship of Samsung.
Experience:| 2011 to Present |
President and CEO, Samsung BioLogics |
|---|---|
| 2008 - 2011 | EVP, Strategic Business Development, Samsung Electronics |
| 2007 - 2008 | Senior VP, Corporate Strategy, Samsung Group Headquarters |
| 2003 - 2007 | Senior VP, Samsung Total Joint Venture |
| 1995 - 2003 | VP and General Manager, Samsung General Chemicals |
| 1992 - 1995 | General Manager, Strategic Planning Chairman’s Office of Samsung Group |
| 1979 - 1992 | Research and Process Engineer, Samsung Central R&D and manufacturing plants |
| 2006 | CEO Course of Wharton Business School |
|---|---|
| 1983 - 1988 | MS and PhD in Chemical Engineering, University of Texas at Austin |
| 1975 - 1979 | BS in Polymer Science, Kyungbook National University |
Chairman, Korea Biomedicine Industry Association
Senior Member, National Academy of Engineering of Korea
Member, Korean Society of Biotechnology and Bioengineering
He has been married for 27 years, and has two daughters
